New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains

被引:79
作者
Chevalier, J
Atifi, S
Eyraud, A
Mahamoud, A
Barbe, J
Pagès, JM
机构
[1] Univ Mediterranee, Fac Med, F-13385 Marseille 05, France
[2] Univ Mediterranee, Fac Pharm, CNRS, UMR 6009,GERCTOP, F-13385 Marseille, France
关键词
D O I
10.1021/jm010911z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Enterobacter aerogenes, one of the most frequently isolated nosocomial pathogens in France, is exhibiting increasing multidrug resistance mechanisms associated with a change in membrane permeability. For drugs of the quinolone family, mutations in the target and active efflux play a prominent role in the resistance. We report here the effect of several pyridoquinoline derivatives that restore a noticeable fluoroquinolone accumulation to resistant strains that overexpress the MarA activator. Studies of the energy-dependent quinolone efflux indicate that the most efficient derivatives tested probably inhibit the resistance process by acting as substrate competitors on the pump extruding intracellular norfloxacin.
引用
收藏
页码:4023 / 4026
页数:4
相关论文
共 32 条
[21]   THE SYNTHESIS OF PYRIDOQUINOLINES WITH DIALKYLAMINOPROPYLAMINE SIDE-CHAINS [J].
MOLOCK, FF ;
BOYKIN, DW .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1983, 20 (03) :681-686
[22]   INHIBITION OF THE TETRACYCLINE EFFLUX ANTIPORT PROTEIN BY 13-THIO-SUBSTITUTED 5-HYDROXY-6-DEOXYTETRACYCLINES [J].
NELSON, ML ;
PARK, BH ;
ANDREWS, JS ;
GEORGIAN, VA ;
THOMAS, RC ;
LEVY, SB .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (03) :370-377
[23]   Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein [J].
Nelson, ML ;
Levy, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1719-1724
[24]   EFFLUX-MEDIATED MULTIDRUG RESISTANCE IN BACILLUS-SUBTILIS - SIMILARITIES AND DISSIMILARITIES WITH THE MAMMALIAN SYSTEM [J].
NEYFAKH, AA ;
BIDNENKO, VE ;
CHEN, LB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4781-4785
[25]   Multidrug efflux pumps of gram-negative bacteria [J].
Nikaido, H .
JOURNAL OF BACTERIOLOGY, 1996, 178 (20) :5853-5859
[26]   PREVENTION OF DRUG ACCESS TO BACTERIAL TARGETS - PERMEABILITY BARRIERS AND ACTIVE EFFLUX [J].
NIKAIDO, H .
SCIENCE, 1994, 264 (5157) :382-388
[27]   AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants [J].
Okusu, H ;
Ma, D ;
Nikaido, H .
JOURNAL OF BACTERIOLOGY, 1996, 178 (01) :306-308
[28]   Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin [J].
Renau, TE ;
Léger, R ;
Flamme, EM ;
Sangalang, J ;
She, MW ;
Yen, R ;
Gannon, CL ;
Griffith, D ;
Chamberland, S ;
Lomovskaya, O ;
Hecker, SJ ;
Lee, VJ ;
Ohta, T ;
Nakayama, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) :4928-4931
[29]   The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus [J].
Schmitz, FJ ;
Fluit, AC ;
Lückefahr, M ;
Engler, B ;
Hofmann, B ;
Verhoef, J ;
Heinz, HP ;
Hadding, U ;
Jones, ME .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :807-810
[30]   RESISTANCE TO ANTIBIOTICS MEDIATED BY TARGET ALTERATIONS [J].
SPRATT, BG .
SCIENCE, 1994, 264 (5157) :388-393